Viking Therapeutics (VKTX) is down -40.1%, or -$16.88 to $25.21.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VKTX:
- Morning Movers: Nexstar and Tegna jump following merger deal
- Eli Lilly, Novo Nordisk up 2% each after Viking obesity pill trial results
- Video: Intel, Viking Therapeutics amid early market movers
- JPMorgan says Viking weight loss drug still offers strong efficacy
- Why Is Viking Therapeutics Stock (VKTX) Down 40% Today?